Heterozygote advantage at HLA class I and II loci and reduced risk of colorectal cancer

Heterozygote advantage at HLA class I and II loci and reduced risk of colorectal cancer

ObjectiveReduced diversity at Human Leukocyte Antigen (HLA) loci may adversely affect the host’s ability to recognize tumor neoantigens and subsequently increase disease burden. We hypothesized that increased heterozygosity at HLA loci is associated with a reduced risk of developing colorectal cance...

Full description

Bibliographic Details
Main Authors: Ya-Yu Tsai, Chenxu Qu, Joseph D. Bonner, Rebeca Sanz-Pamplona, Sidney S. Lindsey, Marilena Melas, Kevin J. McDonnell, Gregory E. Idos, Christopher P. Walker, Kevin K. Tsang, Diane M. Da Silva, Ferran Moratalla-Navarro, Asaf Maoz, Hedy S. Rennert, W. Martin Kast, Joel K. Greenson, Victor Moreno, Gad Rennert, Stephen B. Gruber, Stephanie L. Schmit
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-10-01
Series:Frontiers in Immunology
Subjects:
heterozygote advantage
human leukocyte antigen
heterozygosity
HLA diversity
colorectal cancer
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2023.1268117/full

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2023.1268117/full

Similar Items